LAUREN ALEXANDRA BAUMA

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner TRENTON, NJ NPI 1245932003

General Payments — all program years on this page

$552.81

  • Category: General Payments
  • Program years: PY2023–2024
  • Record count: 34
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $319.39 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $319.3919

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2023 $233.4215
2024 $319.3919

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086747569 Novartis Pharmaceuticals Corporation $15.34 02/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086747571 Novartis Pharmaceuticals Corporation $22.06 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086747573 Novartis Pharmaceuticals Corporation $17.57 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086747579 Novartis Pharmaceuticals Corporation $19.12 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086747583 Novartis Pharmaceuticals Corporation $15.09 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117199566 Amgen Inc. $16.03 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117199569 Amgen Inc. $18.94 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117933347 Boehringer Ingelheim Pharmaceuticals, Inc. $14.22 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117933349 Boehringer Ingelheim Pharmaceuticals, Inc. $16.34 10/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141764045 Merck Sharp & Dohme LLC $15.25 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141764047 Merck Sharp & Dohme LLC $16.80 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141764201 Merck Sharp & Dohme LLC $18.98 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141890714 Merck Sharp & Dohme LLC $15.27 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141939363 Merck Sharp & Dohme LLC $15.27 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154881067 Kiniksa Pharmaceuticals International, plc $15.77 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154881081 Kiniksa Pharmaceuticals International, plc $16.70 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154881117 Kiniksa Pharmaceuticals International, plc $16.93 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154881133 Kiniksa Pharmaceuticals International, plc $16.93 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154881183 Kiniksa Pharmaceuticals International, plc $16.78 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.